ARCHIVES

Taxol Patents Reveal Bristol Strategy to Safeguard Market Against Competitors

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Researchers Take “Director’s Challenge” to Develop Molecular Profiles of Tumors

December 10, 1999

Cancer Meetings Listed

October 24, 1997

DCCR Community Oncology Program RFP Now Ready

April 27, 1979

In Brief: Control Grant Review committee Out Of Grants Division Provisional Training Announcement Due

October 10, 1975

Avon Awards $30M To 13 Organizations

September 27, 2002

Pathology Review Confirms Reserpine As Carcinogen

March 14, 1980